S. Gargosky

发表

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics.

Z. Gucev, V. Hwa, R. Rosenfeld, 1996, The international journal of biochemistry & cell biology.

A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction.

L. Giudice, M. Druzin, Y. El‐Sayed, 2002, The Journal of clinical endocrinology and metabolism.

Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.

J. Guevara-Aguirre, A. Rosenbloom, R. Rosenfeld, 1993, The Journal of clinical endocrinology and metabolism.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.

L. Giudice, J. Irwin, R. Rosenfeld, 1994, The Journal of clinical endocrinology and metabolism.

The mouse intraovarian insulin-like growth factor I system: departures from the rat paradigm.

E. Adashi, C. Bondy, J. Zhou, 1997, Endocrinology.

Direct administration of insulin-like growth factor to fetal rhesus monkeys (Macaca mulatta).

A. Tarantal, S. Gargosky, M. K. Hunter, 1997, Endocrinology.

Hematologic and growth-related effects of frequent prenatal ultrasound exposure in the long-tailed macaque (Macaca fascicularis).

W. O’Brien, A. Hendrickx, A. Tarantal, 1995, Ultrasound in medicine & biology.

Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth.

L. Giudice, L. de las Fuentes, F. de Zegher, 1995, The Journal of clinical endocrinology and metabolism.

Activin-attenuated expression of transcripts encoding granulosa cell-derived insulin-like growth factor binding proteins 4 and 5 in the rat: a putative antiatretic effect.

E. Adashi, R. Rosenfeld, R. Rohan, 1997, Biology of reproduction.

Insulin-like growth factor-I (IGF-I) and IGF-binding proteins both decline in the rat during late pregnancy.

J. Wallace, F. Ballard, P. Walton, 1990, The Journal of endocrinology.

Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.

S. E. Knowles, F. Ballard, F. Tomas, 1991, The Journal of endocrinology.

Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children.

R. Eckel, R. Rosenfeld, B. Jeffers, 1998, The Journal of clinical endocrinology and metabolism.

High-dose growth hormone treatment of short children born small for gestational age.

F. de Zegher, L. Breysem, M. Craen, 1996, The Journal of clinical endocrinology and metabolism.

The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.

R. Baxter, J. Guevara-Aguirre, A. Rosenbloom, 1993, The Journal of clinical endocrinology and metabolism.

Regulation of Postjatal Intestinal Maturation by Growth Hormone: Studies in Rats with Isolated Growth Hormone Deficiency

R. Castillo, S. Gargosky, K. Dahlstrom, 1996, Pediatric Research.

Circulating levels of insulin-like growth factors increase and molecular forms of their serum binding proteins change with human pregnancy.

J. Wallace, J. Owens, J. Robinson, 1990, Biochemical and biophysical research communications.

Characterization of the insulin-like growth factor (IGF) axis in the serum of maternal and fetal macaques (Macaca mulatta and Macaca fascicularis).

A. Tarantal, S. Gargosky, 1995, Growth regulation.

Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.

K. Iwasaki, R. Rosenfeld, T. Matsumoto, 1996, The Journal of clinical endocrinology and metabolism.

Insulin‐like growth factor binding proteins and their regulation

Y. Oh, P. Fielder, R. Rosenfeld, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Transcriptional and post-translational regulation of insulin-like growth factor-binding protein-5 in rat articular chondrocytes.

Tomoko Matsumoto, R. Rosenfeld, Y. Oh, 1996, The Journal of endocrinology.

Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.

J. Guevara-Aguirre, V. Martinez, A. Rosenbloom, 1997, The Journal of clinical endocrinology and metabolism.

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

B. Fox, R. Pierce, A. Daud, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.

Brendan H. Lee, J. Marier, G. Diaz, 2010, Molecular genetics and metabolism.

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis

B. Scharschmidt, M. Lowe, Xunjun Xiao, 2010, Hepatology.

IGF-II and IGF-binding proteins increase dramatically during rabbit pregnancy.

N. Binder, R. Rosenfeld, S. Gargosky, 1996, The Journal of endocrinology.

A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency.

J. Guevara-Aguirre, V. Martinez, A. Rosenbloom, 1995, The Journal of clinical endocrinology and metabolism.

Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.

C. Deal, R. Azziz, H. Potter, 1994, The Journal of clinical endocrinology and metabolism.

Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I.

S. E. Knowles, F. Ballard, F. Tomas, 1991, The Biochemical journal.

Immunoblot studies of the acid‐labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long‐term therapy with GH or IGF‐I respectively

J. Argente, J. Guevara-Aguirre, Phillip D. K. Lee, 1997, Clinical endocrinology.

The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children

S. Mandel, R. Rosenfeld, S. Gargosky, 1997, Endocrine.

Collection of blood in heparinized tubes does not alter the molecular distribution or forms of IGFBP-3 and IGF

S. Mandel, R. Rosenfeld, S. Gargosky, 1996, Endocrine.

Different molecular and messenger ribonucleic acid forms of insulin-like growth factor-binding protein-3 in the pregnant baboon (Papio anubis).

L. Giudice, A. Fazleabas, R. Rosenfeld, 1995, The Journal of endocrinology.

Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.

R. Hintz, R. Rosenfeld, Y. Oh, 1993, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor binding proteins in sera of pregnant nonhuman primates.

L. Giudice, L. de las Fuentes, R. Stouffer, 1993, Endocrinology.

Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo.

L. Giudice, R. Hintz, R. Rosenfeld, 1993, Growth regulation.

Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.

L. Giudice, F. Liu, R. Rosenfeld, 1992, Endocrinology.

MUC1 (CD227): a multi-tasked molecule

V. Apostolopoulos, L. Stojanovska, S. Gargosky, 2015, Cellular and Molecular Life Sciences.

Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study.

J. Rabinovici, N. Cataldo, N. Gesundheit, 1997, The Journal of clinical endocrinology and metabolism.

Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line.

R. Rosenfeld, T. Matsumoto, K. Kelley, 1996, Growth regulation.

Darrell M. Wilson, L. Giudice, M. Druzin, 2002, The Journal of clinical endocrinology and metabolism.

Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during human pregnancy.

J. Wallace, J. Owens, F. Ballard, 1991, The Journal of endocrinology.

Assays for insulin-like growth factors and their binding proteins: practicalities and pitfalls.

R. Rosenfeld, S. Gargosky, R. G. Rosenfeld, 1996, The Journal of pediatrics.

Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.

P. Tapanainen, R. Rosenfeld, S. Gargosky, 1994, Endocrinology.

Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.

P. Tapanainen, Y. Hasegawa, R. Rosenfeld, 1993, The Journal of clinical endocrinology and metabolism.

Insulin-Like Growth Factor Binding Protein-3 Concentrations and Insulin-Like Growth Factor Binding Protein-3 Protease Activity in Sera of Patients with Malignant Solid Tumors or Leukemia

R. Rosenfeld, Y. Oh, K. Wilson, 1994, Pediatric Research.

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

H. Kohrt, J. Berek, A. Secord, 2016, Journal of Immunotherapy for Cancer.

Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.

R. Rosenfeld, Y. Oh, M. Macgillivray, 1995, The Journal of clinical endocrinology and metabolism.

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

B. Fox, R. Pierce, M. Pittet, 2020, Clinical Cancer Research.

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

M. Quinn, G. Pietersz, B. Loveland, 2014, Journal of Immunotherapy for Cancer.

In Situ Transfection of Interleukin 12 Plasmid Enhances Anti-PD-1 Immune Response in Patients with Immunologically Quiescent Melanoma

A. Olshen, B. Fox, M. Pittet, 2019, SSRN Electronic Journal.

Transcriptional and Posttranscriptional Regulation of Intraovarian Insulin-Like Growth Factor-Binding Proteins by Interleukin-1β (IL-1β): Evidence for IL-1β as an Antiatretic Principal.

E. Adashi, Tomoko Matsumoto, R. Rosenfeld, 1999, Endocrinology.

Insulin-like growth factors (IGFs): Implications for aging

L. Giudice, P. Cohen, R. Rosenfeld, 1992, Psychoneuroendocrinology.

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

R. Pierce, D. Byrd, A. Daud, 2019, Clinical Cancer Research.

MUC1 (CD227): a multi-tasked molecule

V. Apostolopoulos, L. Stojanovska, S. Gargosky, 2015, Cellular and Molecular Life Sciences.

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

J. Berek, A. Secord, H. Gray, 2013, Journal of Immunotherapy for Cancer.

Qualification of an intracellular cytokine staining (ICS) assay to evaluate mucin 1-specific T cell responses in ovarian cancer patients treated with CVAC immunotherapy

H. Maecker, S. Gargosky, S. Gupta, 2013 .

Qualification of the COSTIM assay to determine potency and use in clinical trials

J. Lehmann, J. Knauer, M. Buchholz, 2013 .

Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).

R. Pierce, A. Daud, R. Connolly, 2017, Immunotherapy.

The Role of Growth Hormone in Adaptation to Massive Small Intestinal Resection in Rats

R. Castillo, S. Gargosky, K. Dahlstrom, 2001, Pediatric Research.

Regulation of postnatal intestinal maturation by growth hormone: studies in rats with isolated growth hormone deficiency.

R. Castillo, S. Gargosky, K. Dahlstrom, 1996, Pediatric Research.

Upregulation of GH receptor and GH binding protein during pregnancy in the GH deficient rat

B. Breier, R. Borski, R. Barnard, 1995, Endocrine.

Medical and Scientific Aspects of Growth Hormone Receptor Deficiency (Laron Syndrome) in Ecuador

J. Guevara-Aguirre, A. Rosenbloom, R. Rosenfeld, 1994 .

Administration of insulin-like growth factor-I, but not growth hormone, increases maternal weight gain in late pregnancy without affecting fetal or placental growth.

J. Wallace, J. Owens, F. Ballard, 1991, The Journal of endocrinology.

Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.

P. Tapanainen, R. Rosenfeld, S. Gargosky, 1993, The Journal of endocrinology.

Characterization of insulin-like growth factor-binding proteins in rat serum, lymph, cerebrospinal and amniotic fluids, and in media conditioned by liver, bone and muscle cells.

J. Wallace, F. Ballard, P. Walton, 1990, The Journal of endocrinology.

Transcriptional and Posttranscriptional Regulation of Intraovarian Insulin-Like Growth Factor-Binding Proteins by Interleukin-1 b (IL-1 b ): Evidence for IL-1 b as an Antiatretic Principal*

E. Adashi, R. Rosenfeld, C. Resnick, 1999 .

Effects of viral virulence on intrauterine growth in SIV-infected fetal rhesus macaques (Macaca mulatta).

A. Hendrickx, C. Miller, A. Tarantal, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells.

J. Wallace, F. Ballard, S. Gargosky, 1987, The Biochemical journal.

Progression-free survival in ovarian cancer patients in second remission with mucin-1 autologous dendritic cell therapy.

H. Gray, S. Gargosky, C. Team, 2014 .

Insulin-like growth factor binding protein production in human follicular thyroid carcinoma cells.

L. Bachrach, P. Tapanainen, R. Rosenfeld, 1995, Growth regulation.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .